<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39335454</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2227-9059</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>23</Day></PubDate></JournalIssue><Title>Biomedicines</Title><ISOAbbreviation>Biomedicines</ISOAbbreviation></Journal><ArticleTitle>New-Onset Chronic Musculoskeletal Pain Following COVID-19 Infection Fulfils the Fibromyalgia Clinical Syndrome Criteria: A Preliminary Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1940</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biomedicines12091940</ELocationID><Abstract><AbstractText>New-onset chronic musculoskeletal (MSK) pain (&gt;3 months duration) is a common symptom of post-COVID-19 syndrome (PCS). This study aimed to characterise new-onset chronic MSK pain in patients with PCS and its overlap with Fibromyalgia Syndrome (FMS). We enrolled patients with new-onset chronic MSK pain post-COVID-19 and assessed the nature of the pain and associated symptoms using the C19-YRS (Yorkshire Rehabilitation Scale). The FMS assessment was conducted as part of a standard clinical examination using the American College of Rheumatology (ACR) 2010 criteria: (1) Widespread Pain Index (WPI) &#x2265; 7 and symptoms severity (SS) score &#x2265; 5, or WPI between 3 and 6 and SS score &#x2265; 9, (2) symptoms consistent for at least 3 months, and (3) no alternative diagnosis. Of the eighteen patients (average age 49.6 (SD 11.8) years; BMI 31.7 (SD 8.6)), twelve were female. The average symptom duration was 27.9 (SD 6.97) months post-infection. Thirteen patients (72.2%) met the FMS criteria, with an average WPI score of 8.8 and an average SS score of 8.2, indicating a high level of pain and significant quality of life impacts. These findings support the hypothesis that FMS may develop as a long-term sequela of a viral infection, underscoring the need for further research into post-viral long-term conditions.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Khoja</LastName><ForeName>Omar</ForeName><Initials>O</Initials><Identifier Source="ORCID">0000-0002-3978-6253</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mulvey</LastName><ForeName>Matthew</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Academic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds LS2 9NL, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Astill</LastName><ForeName>Sarah</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-9443-6934</Identifier><AffiliationInfo><Affiliation>School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Ai Lyn</ForeName><Initials>AL</Initials><Identifier Source="ORCID">0000-0002-9158-7243</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivan</LastName><ForeName>Manoj</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-0334-2968</Identifier><AffiliationInfo><Affiliation>Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, Leeds LS7 4SA, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>COVID Rehabilitation Service, Leeds Community Healthcare NHS Trust, Leeds LS11 0DL, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomedicines</MedlineTA><NlmUniqueID>101691304</NlmUniqueID><ISSNLinking>2227-9059</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">FM syndrome</Keyword><Keyword MajorTopicYN="N">chronic pain</Keyword><Keyword MajorTopicYN="N">chronic widespread pain</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19 condition</Keyword><Keyword MajorTopicYN="N">post-acute infection syndrome (PAIS)</Keyword><Keyword MajorTopicYN="N">post-acute sequela</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest. This paper has been uploaded to medRxiv as a preprint. doi: https://doi.org/10.1101/2024.07.10.24310234.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39335454</ArticleId><ArticleId IdType="pmc">PMC11429044</ArticleId><ArticleId IdType="doi">10.3390/biomedicines12091940</ArticleId><ArticleId IdType="pii">biomedicines12091940</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE) Scottish Intercollegiate Guidelines Network (SIGN) Royal College of General Practitioners (RCGP)  COVID-19 Rapid Guideline: Managing the Long-term Effects of COVID-19. 2022.  [(accessed on 13 July 2024)]. pp. 1&#x2013;106. Available online:  https://www.nice.org.uk/guidance/ng188.</Citation></Reference><Reference><Citation>Bull-Otterson L., Baca S., Saydah S., Boehmer T.K., Adjei S., Gray S., Harris A.M. Post-COVID Conditions Among Adult COVID-19 Survivors Aged 18&#x2013;64 and &#x2265;65 Years. MMWR Morb. Mortal. Wkly. Rep. 2022;71:713&#x2013;717. doi: 10.15585/mmwr.mm7121e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7121e1</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bosworth M., King S. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 30 March 2023.  [(accessed on 13 July 2024)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/30march2023.</Citation></Reference><Reference><Citation>Khoja O., Passadouro B.S., Mulvey M., Delis I., Astill S., Tan A.L., Sivan M. Clinical Characteristics and Mechanisms of Musculoskeletal Pain in Long COVID. J. Pain Res. 2022;15:1729&#x2013;1748. doi: 10.2147/JPR.S365026.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S365026</ArticleId><ArticleId IdType="pmc">PMC9212788</ArticleId><ArticleId IdType="pubmed">35747600</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-Las-Pe&#xf1;as C., Navarro-Santana M.P., Plaza-Manzano G., Palacios-Ce&#xf1;a D., Arendt-Nielsen L.D.M. Time course prevalence of post-COVID pain symptoms of musculoskeletal origin in patients who had survived severe acute respiratory syndrome coronavirus 2 infection: A systematic review and meta-analysis. Pain. 2021;163:1220&#x2013;1231. doi: 10.1097/j.pain.0000000000002496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002496</ArticleId><ArticleId IdType="pubmed">34561390</ArticleId></ArticleIdList></Reference><Reference><Citation>Cieza A., Causey K., Kamenov K., Hanson S.W., Chatterji S., Vos T. Global Estimates of the Need for Rehabilitation Based on the Global Burden of Disease Study 2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet. 2021;396:2006&#x2013;2017. doi: 10.1016/S0140-6736(20)32340-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32340-0</ArticleId><ArticleId IdType="pmc">PMC7811204</ArticleId><ArticleId IdType="pubmed">33275908</ArticleId></ArticleIdList></Reference><Reference><Citation>Khoja O., Silva-Passadouro B., Cristescu E., McEwan K., Doherty D., O&#x2019;Connell F., Ponchel F., Mulvey M., Astill S., Tan A.L., et al. Clinical Characterization of New-Onset Chronic Musculoskeletal Pain in Long COVID: A Cross-Sectional Study. J. Pain Res. 2024;17:2531&#x2013;2550. doi: 10.2147/JPR.S466294.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/JPR.S466294</ArticleId><ArticleId IdType="pmc">PMC11298172</ArticleId><ArticleId IdType="pubmed">39100135</ArticleId></ArticleIdList></Reference><Reference><Citation>Fialho M.F.P., Brum E.S., Oliveira S.M. Could the Fibromyalgia Syndrome Be Triggered or Enhanced by COVID-19? Inflammopharmacology. 2023;31:633&#x2013;651. doi: 10.1007/s10787-023-01160-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-023-01160-w</ArticleId><ArticleId IdType="pmc">PMC9970139</ArticleId><ArticleId IdType="pubmed">36849853</ArticleId></ArticleIdList></Reference><Reference><Citation>Haider S., Janowski A.J., Lesnak J.B., Hayashi K., Dailey D.L., Chimenti R., Frey-Law L.A., Sluka K.A., Berardi G. A Comparison of Pain, Fatigue, and Function between Post-COVID-19 Condition, Fibromyalgia, and Chronic Fatigue Syndrome: A Survey Study. Pain. 2023;164:385&#x2013;401. doi: 10.1097/j.pain.0000000000002711.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/j.pain.0000000000002711</ArticleId><ArticleId IdType="pmc">PMC9797623</ArticleId><ArticleId IdType="pubmed">36006296</ArticleId></ArticleIdList></Reference><Reference><Citation>Clauw D.J. Fibromyalgia: A Clinical Review. JAMA. 2014;311:1547&#x2013;1555. doi: 10.1001/jama.2014.3266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2014.3266</ArticleId><ArticleId IdType="pubmed">24737367</ArticleId></ArticleIdList></Reference><Reference><Citation>Borchers A.T., Gershwin M.E. Fibromyalgia: A Critical and Comprehensive Review. Clin. Rev. Allergy Immunol. 2015;49:100&#x2013;151. doi: 10.1007/s12016-015-8509-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12016-015-8509-4</ArticleId><ArticleId IdType="pubmed">26445775</ArticleId></ArticleIdList></Reference><Reference><Citation>Woolf C.J. Central sensitization: Implications for the diagnosis and treatment of pain. Pain. 2011;152:S2&#x2013;S15. doi: 10.1016/j.pain.2010.09.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pain.2010.09.030</ArticleId><ArticleId IdType="pmc">PMC3268359</ArticleId><ArticleId IdType="pubmed">20961685</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams D.A., Clauw D.J. Understanding Fibromyalgia: Lessons from the Broader Pain Research Community. J. Pain. 2009;10:777&#x2013;791. doi: 10.1016/j.jpain.2009.06.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpain.2009.06.001</ArticleId><ArticleId IdType="pmc">PMC2741022</ArticleId><ArticleId IdType="pubmed">19638325</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips K., Clauw D.J. Central Pain Mechanisms in the Rheumatic Diseases: Future Directions. Arthritis Rheum. 2013;65:291&#x2013;302. doi: 10.1002/art.37739.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.37739</ArticleId><ArticleId IdType="pmc">PMC3610409</ArticleId><ArticleId IdType="pubmed">23045168</ArticleId></ArticleIdList></Reference><Reference><Citation>Siracusa R., Di Paola R., Cuzzocrea S., Impellizzeri D. Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update. Int. J. Mol. Sci. 2021;22:3891. doi: 10.3390/ijms22083891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22083891</ArticleId><ArticleId IdType="pmc">PMC8068842</ArticleId><ArticleId IdType="pubmed">33918736</ArticleId></ArticleIdList></Reference><Reference><Citation>Buskila D., Atzeni F., Sarzi-Puttini P. Etiology of Fibromyalgia: The Possible Role of Infection and Vaccination. Autoimmun. Rev. 2008;8:41&#x2013;43. doi: 10.1016/j.autrev.2008.07.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2008.07.023</ArticleId><ArticleId IdType="pubmed">18706528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ablin J.N., Shoenfeld Y., Buskila D. Fibromyalgia, Infection and Vaccination: Two More Parts in the Etiological Puzzle. J. Autoimmun. 2006;27:145&#x2013;152. doi: 10.1016/j.jaut.2006.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2006.09.004</ArticleId><ArticleId IdType="pubmed">17071055</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursini F., Ciaffi J., Mancarella L., Lisi L., Brusi V., Cavallari C., D&#x2019;onghia M., Mari A., Borlandelli E., Cordella J.F., et al. Fibromyalgia: A new facet of the post-COVID-19 syndrome spectrum? Results from a web-based survey. RMD Open. 2021;7:e001735. doi: 10.1136/rmdopen-2021-001735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/rmdopen-2021-001735</ArticleId><ArticleId IdType="pmc">PMC8384499</ArticleId><ArticleId IdType="pubmed">34426540</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva-Passadouro B., Tamasauskas A., Khoja O., Casson A.J., Delis I., Brown C., Sivan M. A Systematic Review of Quantitative EEG Findings in Fibromyalgia, Chronic Fatigue Syndrome and Long COVID. Clin. Neurophysiol. 2024;163:209&#x2013;222. doi: 10.1016/j.clinph.2024.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2024.04.019</ArticleId><ArticleId IdType="pubmed">38772083</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Halpin S., Gee J. Assessing Long-Term Rehabilitation Needs in COVID-19 Survivors Using a Telephone Screening Tool (C19-YRS Tool) Adv. Clin. Neurosci. Rehabil. 2020;19:14&#x2013;17. doi: 10.47795/NELE5960.</Citation><ArticleIdList><ArticleId IdType="doi">10.47795/NELE5960</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Clauw D.J., Fitzcharles M.-A., Goldenberg D.L., Katz R.S., Mease P., Russell A.S., Russell I.J., Winfield J.B., Yunus M.B. The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom Severity. Arthritis Care Res. 2010;62:600&#x2013;610. doi: 10.1002/acr.20140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.20140</ArticleId><ArticleId IdType="pubmed">20461783</ArticleId></ArticleIdList></Reference><Reference><Citation>Galvez-S&#xe1;nchez C.M., Reyes Del Paso G.A. Diagnostic Criteria for Fibromyalgia: Critical Review and Future Perspectives. J. Clin. Med. 2020;9:1219. doi: 10.3390/jcm9041219.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9041219</ArticleId><ArticleId IdType="pmc">PMC7230253</ArticleId><ArticleId IdType="pubmed">32340369</ArticleId></ArticleIdList></Reference><Reference><Citation>Savin E., Rosenn G., Tsur A.M., Hen O., Ehrenberg S., Gendelman O., Buskila D., Halpert G., Amital D., Amital H. The Possible Onset of Fibromyalgia Following Acute COVID-19 Infection. PLoS ONE. 2023;18:e0281593. doi: 10.1371/journal.pone.0281593.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281593</ArticleId><ArticleId IdType="pmc">PMC9916594</ArticleId><ArticleId IdType="pubmed">36763625</ArticleId></ArticleIdList></Reference><Reference><Citation>Wolfe F., Clauw D.J., Fitzcharles M.A., Goldenberg D.L., H&#xe4;user W., Katz R.L., Mease P.J., Russell A.S., Russell I.J., Walitt B. 2016 Revisions to the 2010/2011 Fibromyalgia Diagnostic Criteria. Semin. Arthritis Rheum. 2016;46:319&#x2013;329. doi: 10.1016/j.semarthrit.2016.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2016.08.012</ArticleId><ArticleId IdType="pubmed">27916278</ArticleId></ArticleIdList></Reference><Reference><Citation>Akel A., Almanasyeh B., Kobaa A.A., Aljabali A., Al-Abadleh A., Alkhalaileh A., Alwardat A.R., Sarhan M.Y., Abu-Jeyyab M. A Cross-Sectional Study of Fibromyalgia and Post-acute COVID-19 Syndrome (PACS): Could There Be a Relationship? Cureus. 2023;15:e42663. doi: 10.7759/cureus.42663.</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.42663</ArticleId><ArticleId IdType="pmc">PMC10462402</ArticleId><ArticleId IdType="pubmed">37644924</ArticleId></ArticleIdList></Reference><Reference><Citation>Bileviciute-Ljungar I., Norrefalk J.-R., Borg K. Pain Burden in Post-COVID-19 Syndrome Following Mild COVID-19 Infection. J. Clin. Med. 2022;11:771. doi: 10.3390/jcm11030771.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm11030771</ArticleId><ArticleId IdType="pmc">PMC8836662</ArticleId><ArticleId IdType="pubmed">35160223</ArticleId></ArticleIdList></Reference><Reference><Citation>Adak B., Tekeo&#x1e7;lu &#xcd;., Ediz L., Budancamanak M., Yazgan T., Karahocagil K., Demirel A. Fibromyalgia Frequency in Hepatitis B Carriers. J. Clin. Rheumatol. 2005;11:157&#x2013;159. doi: 10.1097/01.rhu.0000165291.91623.5c.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.rhu.0000165291.91623.5c</ArticleId><ArticleId IdType="pubmed">16357736</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruz B.A., Catalan-Soares B., Proietti F. Higher Prevalence of Fibromyalgia in Patients Infected with Human T Cell Lymphotropic Virus Type I. J. Rheumatol. 2006;33:2300&#x2013;2303.</Citation><ArticleIdList><ArticleId IdType="pubmed">17086610</ArticleId></ArticleIdList></Reference><Reference><Citation>Hunskar G.S., Rortveit G., Litleskare S., Eide G.E., Hanevik K., Langeland N., Wensaas K.A. Prevalence of Fibromyalgia 10 Years after Infection with Giardia Lamblia: A Controlled Prospective Cohort Study. Scand. J. Pain. 2022;22:348&#x2013;355. doi: 10.1515/sjpain-2021-0122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/sjpain-2021-0122</ArticleId><ArticleId IdType="pubmed">34679267</ArticleId></ArticleIdList></Reference><Reference><Citation>Cairns V., Godwin J. Post-Lyme Borreliosis Syndrome: A Meta-Analysis of Reported Symptoms. Int. J. Epidemiol. 2005;34:1340&#x2013;1345. doi: 10.1093/ije/dyi129.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ije/dyi129</ArticleId><ArticleId IdType="pubmed">16040645</ArticleId></ArticleIdList></Reference><Reference><Citation>Colas C., Jumel A., Vericel M.-P., Barth N., Manzanares J., Goutte J., Fontana L., F&#xe9;asson L., Hupin D., Guyot J. Understanding Experiences of Fibromyalgia Patients Involved in the Fimouv Study During COVID-19 Lockdown. Front. Psychol. 2021;12:645092. doi: 10.3389/fpsyg.2021.645092.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2021.645092</ArticleId><ArticleId IdType="pmc">PMC8329548</ArticleId><ArticleId IdType="pubmed">34354626</ArticleId></ArticleIdList></Reference><Reference><Citation>Qi T., Hu T., Ge Q.Q., Zhou X.N., Li J.M., Jiang C.L., Wang W. COVID-19 Pandemic Related Long-Term Chronic Stress on the Prevalence of Depression and Anxiety in the General Population. BMC Psychiatry. 2021;21:380. doi: 10.1186/s12888-021-03385-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-021-03385-x</ArticleId><ArticleId IdType="pmc">PMC8316891</ArticleId><ArticleId IdType="pubmed">34320924</ArticleId></ArticleIdList></Reference><Reference><Citation>Sivan M., Smith A.B., Osborne T., Goodwin M., Lawrence R.R., Baley S., Williams P., Lee C., Davies H., Balasundaram K., et al. Long COVID Clinical Severity Types Based on Symptoms and Functional Disability: A Longitudinal Evaluation. J. Clin. Med. 2024;13:1908. doi: 10.3390/jcm13071908.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13071908</ArticleId><ArticleId IdType="pmc">PMC11012375</ArticleId><ArticleId IdType="pubmed">38610673</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>